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Abstract
Background: Cardiovascular risk management is largely provided in primary healthcare, but not all patients with
established cardiovascular diseases receive preventive treatment as recommended. Accreditation of healthcare
organizations has been introduced across the world with a range of aims, including the improvement of clinical
processes and outcomes. The Dutch College of General Practitioners has launched a program for accreditation of
primary care practices, which focuses on chronic illness care. This study aims to determine the effectiveness and
efficiency of a practice accreditation program, focusing on patients with established cardiovascular diseases.
Methods/design: We have planned a two-arm cluster randomized trial with a block design. Seventy primary care
practices will be recruited from those who volunteer to participate in the practice accreditation program. Primary
care practices will be the unit of randomization. A computer list of random numbers will be generated by an
independent statistician. The intervention group (n = 35 practices) will be instructed to focus improvement on
cardiovascular risk management. The control group will be instructed to focus improvement on other domains in
the first year of the program. Baseline and follow-up measurements at 12 months after receiving the accreditation
certificate are based on a standardized version of the audit in the practice accreditation program. Primary outcomes
include controlled blood pressure, serum cholesterol, and prescription of recommended preventive medication.
Secondary outcomes are 15 process indicators and two outcome indicators of cardiovascular risk management,
self-reported achievement of improvement goals and perceived unintended consequences. The intention to treat
analysis is statistically powered to detect a difference of 10% on primary outcomes. The economic evaluation aims
to determine the efficiency of the program and investigates the relationship between costs, performance indicators,
and accreditation.
Discussion: It is important to gain more information about the effectiveness and efficiency of the practice
accreditation program to assess if participation is worthwhile regarding the quality of cardiovascular risk
management. The results of this study will help to develop the practice accreditation program for primary care
practices.
Trial registration: This cluster randomized trial is registered at ClinicalTrials.gov nr NCT00791362
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Background
Cardiovascular diseases (CVD) remain an important
cause of mortality and morbidity worldwide. In public
health and in primary care, many efforts have been made
to prevent CVD [1,2]. Although cardiovascular care has
improved in recent years [3], a substantial number of
individuals receive suboptimal cardiovascular risk man-
agement (CVRM) and do not attain the lifestyle, risk fac-
tor, and therapeutic targets that are recommended [4,5].
A range of interventions to improve healthcare delivery
is available [6-8]. In recent years, programs have been
developed for performance indicators, accreditation,
pay-for-performance, and public reporting [9]. These
approaches make use of market forces and pressure for
accountability, but research evidence on effectiveness
and efficiency is limited [9-11].
The slow improvement of cardiovascular primary care
may be caused by the one-off and condition-specific
character of many improvement activities (e.g., a con-
tinuing education session or audit without follow-up).
To enhance continuous improvement in primary care in
the Netherlands, the Dutch College of General Practi-
tioners (DCGP) initiated in 2005 a nationwide compre-
hensive practice accreditation program for primary care
practices. This program consists of a systematic audit on
the basis of validated performance indicators for dia-
betes mellitus, CVRM, asthma, chronic obstructive pul-
monary disease (COPD), practice organization, patient
experience, educational feedback to practices, the re-
quirement to develop structured improvement plans,
and a check on the implementation of these plans after
one year. If the procedure is performed, primary care
practices receive a certificate that provides accreditation
for a time period of one year. While accreditation serves
a range of purposes, improvement of professional per-
formance and practice organization are prominent
among these [12-14]. While the impact of audit and
feedback is mixed and moderate [15], it is unknown
what the added value of the accreditation procedure is.
A study of practice accreditation in German primary
care practices showed that it improved aspects of prac-
tice organization, but this study did not measure or as-
sess impact on clinical processes or outcomes [16].
Given the resources invested in accreditation schemes
and the high expectations, an evaluation of the impact
on quality and outcomes of care is needed.
A substantial number of performance indicators used
in the practice accreditation program is related to CVD.
These indicators are derived from the completely revised
guideline on CVRM that was published by the DCGP
late 2005 [17]. The new set of guidelines on CVRM
describes the clinical interventions to be implemented in
patient care in this project. They contain important
changes in recommendations, such as different cut-off
levels (e.g., LDL-cholesterol <2.5 mmol/l and systolic
blood pressure <140 mmHg). The DCGP has developed
a number of products and activities to implement these
guidelines, including a national kick-off conference for
general practitioners (GPs) in December 2005, and a
supportive package (‘kwaliteitskoffer’) consisting of edu-
cational materials and software for assessment of cardio-
vascular risk. The practice accreditation program is an
important approach to improve primary care, but con-
trolled evaluations of its effect have not yet been done.
Aims and objectives
The overall aims of the study are to determine the effect-
iveness and efficiency of the practice accreditation pro-
gram in primary care, focused on its effect on CVRM.
Key objectives are:
1. To determine the effectiveness of the program on
primary performance indicators for CVRM by
comparing practices in the accreditation program
that focus their improvement plans on CVRM to
practices in the accreditation program that focus
their improvement plans on other domains of
chronic care. Primary outcomes are documented
controlled blood pressure, serum cholesterol, and
prescription of recommended preventive medication
(effect evaluation).
2. To determine the potential effect of the program on
other indicators for CVRM, self-reported goal
attainment in the intervention group, and
unintended consequences. Secondary outcomes are
all other indicators for CVRM, self-reported goal
attainment in the intervention group, and
unintended consequences (effect evaluation).
3. To determine the economic efficiency of the
program in the observed period regarding the
primary outcomes.
4. To explore what factors and mechanisms are




The study design is a cluster randomized controlled trial
with a block design, considering primary care practices
as units of clustering.
Ethical approval and informed consent
The Medical Ethics committee Arnhem-Nijmegen waived
approval for this trial. At follow-up practices will send a
letter of invitation and informed consent to 100 patients
with established CVD. Patients return their letter
with informed consent to Radboud University Nijmegen
Medical Centre with permission for audit of their medical
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records. The privacy of the participating patients will be
protected, and all data will be coded and processed an-
onymously. For the baseline-measurement, mandatory in-
formation on indicators for patients with established CVD




Seventy primary care practices will be recruited from
practices in the Netherlands who voluntarily apply to
start the practice accreditation program. An invitation
letter for the study will be sent as part of the instruction
manual for the program. Practices with a clear prefer-
ence for a specific improvement plan will be excluded
from participation in the study while participating prac-
tices will be randomized to a group which starts with an
improvement plan on CVRM or to a group that does
not. This also accounts for practices that participate in
regional programs for enhancing disease management.
Patients
The study focuses on patients with established CVD.
This includes patients with angina pectoris, acute myo-
cardial infarction in their medical history, other chronic
ischemic heart diseases, transient ischemic attack (TIA),
ischemic stroke, peripheral arterial disease, and aneur-
ysma aortae. Selection of patients out of electronic med-
ical records with these conditions will be based on
corresponding diagnostic International Classification of
Primary Care codes (ICPC-codes K74, K75, K76, K89,
K90.3, K92.1 and K99.1), a worldwide system to label
conditions in primary care [18].
Randomization
General practices will be the unit of randomization. A
computer list of random numbers will be generated by
an independent statistician and then used to randomly
allocate practices to equally sized intervention group or
control group. This will be done in a randomized block
design in blocks of four practices in order of enrolment.
We assume that improvement activities in the control
group will not influence cardiovascular care.
The practice accreditation program
The practice accreditation program is an existing pro-
cedure provided since 2005 by an independent body
(NPA) that has a license to use the accreditation proced-
ure developed by the DCGP. The DCGP remains re-
sponsible for the content and further development of
the procedure; it will be responsible for adequate deliv-
ery of the practice accreditation program in this study.
The practice accreditation program comprises, firstly, of
a comprehensive audit (using validated performance
indicators) and written feedback to the practice, which
covers a range of clinical domains (mainly chronic dis-
eases), practice management, and patient experiences.
The feedback, which consists of a comparison with
benchmarks of other primary care practices, is discussed
with a non-physician observer in a feedback consultation
and helps to identify substandard performance. The sec-
ond obligatory component, the planning of improve-
ments in the practice according to the principles of
quality management, is based on this feedback. The
practice team is supported by a trained non-physician
consultant. Practices that perform the procedure as
planned are all accredited, so accreditation does not
imply that a certain minimum score has been obtained
(the latter is usually labeled certification). In the practice
accreditation program, validated instruments are used:
the Visit Instrument to asses Practice management
(Visitatie Instrument Praktijkvoering, VIP) [19], clinical
performance, and Europep [20]. Practices in the program
receive a reimbursement of some insurance companies
consisting of a bonus per patient per year. Furthermore
they receive a certification for the time period of one
year that demonstrates (to the public) their involvement
in continuous quality improvement. Every year the prac-
tice will be audited, and every year new improvement
plans have to be formulated that have to be approved by
the auditor.
Intervention group
The intervention starts with volunteering for the practice
accreditation program. After enrolment for the study,
practices will be contacted by telephone for further ex-
planation of the study protocol and to schedule the data
collection. After data is collected, practices are rando-
mized. Practices allocated to the intervention group are
instructed to focus their improvement plans on cardiovas-
cular diseases in the first year of the program.
Control group
The control group also starts with volunteering for the
practice accreditation program and follows the same
routine as described for the intervention group. Practices
allocated to the control group are instructed to focus
their improvement plans on other domains than cardio-
vascular disease and diabetes mellitus (they may target
CVD later after the study period of one year). They are
instructed to focus their improvement plans on other
clinical areas than CVD or diabetes.
Both intervention and control group receive feedback
on CVD indicators as part of the normal practice ac-
creditation program. Practices in the intervention group
are instructed to set targets related to process and out-
comes of cardiovascular care (and not just focused on
improvement of registration of cardiovascular disease in
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the medical record system). All practices will receive a
minimum of four hours of support by outreach consul-
tants for no cost, which is available in all regions. Also,
the practices are provided with examples of improve-
ment plans, which saves time and would make study
participation more attractive.
Measurement procedures
In each practice measurements are done at baseline and
at follow-up (Figure 1). At baseline, medical records of
40 patients with established CVD are audited as part of
the clinical performance measurements in the practice
accreditation program. Data on performance indicators
of CVRM as included in the practice accreditation pro-
gram will be used for the analysis. At follow up, the fol-
lowing measurement methods will be used: medical
record audit based on the same indicators of CVRM as
in the baseline measurement, patient questionnaires, and
a semi-structured interview for a contact person in each
practice. Data will be collected consistently as this is
done by two persons with similar training.
Measures of effectiveness
The effect evaluation aims to determine the effectiveness
of the program on primary performance indicators for
CVRM and to determine the potential impact of the
program on other indicators for CVRM, self-reported
goal attainment in the intervention group, and unin-
tended consequences.
Primary outcomes have been selected from the 20
quality indicators for established CVD [21], which were
developed by DCGP (Table 1), and are:
1. The percentage of patients in the practice with
known established CVD who have systolic blood
pressure below 140 mmHg.
2. The percentage of patients in the practice with
known established CVD who have LDL cholesterol
below 2.5 mmol/l.
3. The percentage of patients in the practice with
known established CVD with a record that aspirin,
an alternative anti-platelet therapy, or an
anticoagulant has been prescribed.
Data concerning indicators are extracted from medical
records and will be available at patient level so that link-
age to other measures (resource use, patient characteris-
tics) can be made at patient level.
Secondary outcomes consist of the 17 remaining indi-
cators are used and include: measurement of systolic
blood pressure, measurement of LDL-cholesterol, pre-
scription of statin, smoking status, stop smoking advice,
measurement of body mass index (BMI), BMI <25 kg/m2,
measurement of waist circumference, fasting glucose
measurement, influenza vaccination, registration of alco-
hol intake, control and advice for exercise and diet, and
comprehensive risk assessment (Table 1). Furthermore,
secondary outcomes are measured in interviews with the
contact person of the practice and contain perceived goal
70 Practices 
Follow up measurement of cardiovascular 
indicators
Allocated to intervention group (N= 35)
Quality improvement plans on cardiovascular 
risk management
Follow up measurement of cardiovascular 
indicators
Allocated to control group (N=35)









Figure 1 Flow Diagram.
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attainment regarding the improvement plans, which is
measured on a likert scale, and unintended consequences
as result of participating in the practice accreditation
program.
Measures of costs
In follow-up measurements items of use of healthcare
will be extracted from the medical records with a retro-
spective three-month observation period. These items
include number of contacts in the practice (face to face,
telephone, email), use of various types of cardiovascular
medication, use of hospital care or other care providers
for cardiovascular diagnosis or therapy. Additional infor-
mation will be collected with patient questionnaires, par-
ticularly on other healthcare use (e.g., home care) and
productivity losses, using a one-month retrospective ob-
servation period. Also, at follow-up in both groups, time
and other resources of practice teams spent on quality
improvement in the total period of 18 months will be
documented. Data-collection on performance indicators
will be done in the follow-up measurement by medical
record audit.
Other measures
1. Exposure to other quality improvement activities:
Both study groups report on their exposure to
relevant professional education and practice
improvement activities (e.g., training for practice
nurses). This will be measured in semi-structured
telephone interviews.
2. Potential confounders: At follow up, potential
confounders will be measured. These include patient
characteristics, particularly patient age, gender and
multi-morbidity. Furthermore, data on practice
characteristics will be collected. These include
practice size, physician workload, volume of
assistance in the practice, delegation of medical tasks
to assistants, and involvement of practice nurses in
chronic care. These practice characteristics have
shown to be associated with better chronic disease
management in Dutch primary care practices [22].
3. Patient reported outcomes: At follow up, patients
receive questionnaires that include items on
demographic characteristics, labor activities and
healthcare use. Furthermore the EQ-5D (five items
and VAS scale) will be added to measure health
outcome [23]. To measure chronic care delivery, the
Patient Assessment of Chronic Illness Care (PACIC)
will be used [24]. Questionnaires for physical exercise
(RAPA, nine items) [25], and the Treatment Self-
Regulation Questionnaire (TSRQ) [26] to measure
the motivation for being physically active will be
included.
Statistical methods
The study groups will be compared at baseline regarding
known determinants of cardiovascular care and its im-
provement. These include patient factors [27,28] (e.g., age,
multi-morbidity, ethnicity at practice level) and practice
characteristics [22,29] (e.g., availability of nurses, delega-
tion of medical tasks to assistance, practice size). Only fac-
tors emerging from previous research are considered to
avoid overcorrection in the primary analysis. A logistic re-
gression model will be constructed for each outcome to
analyze these outcomes in relation to group (intervention,
control) and measurement moment (baseline, follow-up).
Identified differences between the groups at baseline will
be included in this analysis. Random coefficients will be
included to allow for the clustering of data within prac-
tices. Each of the secondary outcomes (clinical and
organizational indicators) will also be analyzed in this way.
Finally, if an internally consistent scale can be constructed
(reflected by high reliability coefficients of the combined
score), we will develop an aggregated measure of outcome,
and use this in a similar random coefficients linear regres-
sion analysis.
Table 1 Indicators for cardiovascular risk management
Type of indicator
Process Smoking status
Outcome Patient is a smoker
Process Stop smoking advice
Process BMI measured
Outcome BMI < 25 kg/m2
Process Influenza vaccination
Process Exercise control
Process Systolic blood pressure measured
Outcome Systolic blood pressure < 140 mmHg1
Process LDL cholesterol measured
Outcome LDL cholesterol <2.5 mmol/L1
Process Advice physical activity
Process Diet control
Process Counseling about diet
Process Registration of alcohol intake
Process Patients with LDL cholesterol ≥2.5 mmol/L
with statin prescription
Process Waist circumference measured
Process Prescription antiplatelet drugs1
Process Fasting glucose measured
Process Comprehensive risk assessment *
*Positive score when there is a record of: blood pressure, BMI, waist
circumference, fasting glucose measurement, LDL cholesterol measurement,
smoking behavior, alcohol intake, advice and control of diet and physical
exercise in the past 12 months.
1Primary outcome.
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To identify the effectiveness of this program on attain-
ment of practice-defined goals and its perceived unintended
consequences, the second key objective, a descriptive ana-
lysis will be performed aimed at determining what propor-
tion of self-defined goals for improvement was achieved
by the practices and straightforward listing of the GP
views on unintended consequences of the practice ac-
creditation program.
Economic analysis
The economic analysis, the third key objective, aims to de-
termine the efficiency of the program in the observed
period regarding the primary outcomes. The economic
evaluation also investigates the relationship between costs,
performance indicators, and accreditation. The economic
evaluation provides incremental cost-effectiveness ratios:
incremental cost per percentage patients gained with
systolic blood pressure below 140 mmHg; incremental
cost per percentage patients gained with LDL cholesterol
<2.5 mmol/l; incremental cost per percentage patient
gained with aspirin, an alternative anti-platelet therapy or
an anti-coagulant.
For the economic analysis, costs analyses will be based
on the competing health production processes respect-
ively, including and excluding resources attributed to ac-
creditation. Specific unit-costs include, for example
medical care (contacts in primary care practice, tests,
treatments, etc.) and improvement related costs (ac-
creditation tariff, time for audit, planning and imple-
menting improvement, exposure to other relevant
quality improvement, etc.). Units of resources are mon-
etary valued on the basis of prevailing Dutch guidelines
[30] or national CVZ tariffs. The analysis aims to pro-
vide incremental cost-effectiveness ratios (ICERs). The
ICERs will be computed, and uncertainty will be deter-
mined using the bootstrap method to account for
skewness in the underlying parameter distributions. Un-
certainty will be presented in a Bayesian fashion using
cost-effectiveness acceptability curves (CEAC’s) that are
able to evaluate efficiency by using different thresholds
for the ICER (varying the willingness to pay for a per-
centage patients gained for each of the primary out-
comes). Uncertainty in deterministic parameters will be
examined with sensitivity analysis based on the range of
extremes.
Process evaluation
The process evaluation, the fourth key objective, aims to
explore what factors and mechanisms are associated with
change (or absence of change) of performance on CVRM
indicators. Semi-structured telephone interviews will be
held with primary care physician or the quality coordinator
of the practice after data collection for follow-up measure-
ment is concluded. Topics of this interview are: practice
characteristics; feedback reports; composing improvement
plans; and reasons to participate in and experiences with
the practice accreditation program. We want to explore
if specific elements of the practice accreditation pro-
gram are the cause of change in CVRM. All interviews
will be conducted by the same person and will be audio-
recorded. Interviews will be transcribed verbatim. Two
researchers will independently review the transcripts.
Data analysis will be done according to the framework
approach [31]. Topics in the interviews will be used as
coding frame. Software package Atlas ti. will be applied
to analyze qualitative data. The primary analysis of the
interview data aims to identify determinants of (change
of ) practice as perceived by participants.
Sample size
In the practices in the practice accreditation program up
to 2006 (n = 139), the following median values at prac-
tice level were found on indicators referring to patients
with CVD: 53% for acceptable blood pressure levels; 36%
for acceptable cholesterol levels; and 38% for use of
anticoagulents (unpublished data at IQ healthcare, 2005
and 2006). These data suggest that the current scores on
the primary outcomes are in the range of 35% to 55%,
which imply that substantial improvement is possible in
many practices. The proposed study has been powered
to detect a difference of 10% (from 55% to 65%), not yet
taking control for baseline values into account because
of uncertainty regarding the correlation between base-
line and follow-up measures.
We expected that the accreditation and improvement
program will have an effect of 5% to 10% absolute change,
which is the median value of effect sizes in a comprehen-
sive review of 235 studies on quality improvement [14].
Other assumptions were a power = 0.80, alpha = 0.05, and
ICC = 0.05. Given the sample of 30 patients per practice
per indicator, we aimed to include 31 practices in each
group. Allowing for dropout, we aim to include 35 prac-
tices in each group (n = 70 practices in total). This num-
ber is feasible, given the recruitment rate for the
accreditation in 2006.
Time frame of the study
The study is planned from September 2008 until
September 2012. In months 1 to 18, practices are
recruited and included in the project and go through the
accreditation procedure. The baseline data collection will
take place in these months. During months 3 to 42,
practices (in the intervention group) work on improving
their management of CVD, practices in the control
group on improvements in other areas. In months 18 to
42, follow-up measurements in intervention and control
practices are planned. During months 43 to 48, data will
be analyzed and reported.
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Discussion
The sample of participating primary care practices in this
study is composed of volunteers for the practice accredit-
ation program and therefore not nationally representative
for primary care practices in the country. This reflects
current practice, in which practice accreditation is a
voluntary activity. It implies that study results cannot be
generalized to the (currently hypothetical) situation of ob-
ligatory accreditation. Furthermore, we only collect data
on CVRM; therefore, we cannot make statements about
the effects of the program on other chronic illnesses.
Because both intervention and control groups start
with accreditation, this project cannot pick up non-
specific effects of the practice accreditation program.
For example, we expect that practices prepare for ac-
creditation by improving their practice (e.g., involve a
practice nurse). We intend to compare the groups with
other, independent samples of practices that provide
data on cardiovascular care to get an impression of the
representativeness of our sample of practices.
With the results of this study, we hope to make a contri-
bution with regard to further development and adjustment
of the practice accreditation program. Previous research
[32] has shown that the program is time-consuming for
participating practices. Furthermore, it costs a consider-
able amount of money to participate in the program. It is
important to gain more information about the effective-
ness and efficiency of the program to assess if participation
is worthwhile regarding the quality of CVRM. With these
results, stakeholders can make policy and management
decisions with regard to the use of the program.
No data cleaning or analysis has occurred prior to sub-
mission of the manuscript.
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